References
- BradyRALeidJGCostertonJWShirtliffMEOsteomyelitis: clinical overview and mechanisms of infection persistenceClin Microbiol Newsl2006286572
- ZilbermanMElsnerJJAntibiotic-eluting medical devices for various applicationsJ Control Release200813020221518687500
- KluinOSvan der MeiHCBusscherHJNeutDBiodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitisExpert Opin Drug Deliv201310334135123289645
- GiavaresiGBertazzoni MinelliESartoriMMicrobiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitisJ Orthop Res201230334835521882237
- DaiZhenyuLiJunZhaoZHAoXXJiangDMBiological safety of nano-hydroxyapatite and poly-amino acid compoundJ Third Mil Med Univ201032222942299
- HuangJZhaoDDangariaSJCombinatorial design of hydrolytically degradable, bone-like biocomposites based on PHEMA and hydroxyapatitePolymer (Guildf)201354290991923525786
- LuMinpengJiangDianmingQuanZhengxueThe establishment of experimental chronic osteomyelitis induced by Staphylococcus aureus in rabbitsChinese J Exp Surg2010272110113
- NordenCWMyerowitzRLKeletiEExperimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysisBr J Exp Pathol1980614514607426395
- SmeltzerMSThomasJRHickmonSGCharacterization of a rabbit model of staphylococcal osteomyelitisJ Orthop Res1997154144219246088
- YinLYLazzariniLLiFComparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillinresistant Staphylococcus aureus experimental osteomyelitis in a rabbit modelJ Antimicrob Chemother2005556995100215857944
- PollakANJonesALCastilloRCBosseMJMacKenzieEJLEAP Study GroupThe relationship between time to surgical debridement and incidence of infection after open high-energy lower extremity traumaJ Bone Joint Surg Am201092171520048090
- WalterGKemmererMKapplerCHoffmannRTreatment algorithms for chronic osteomyelitisDtsch Arztebl Int20121091425726422536302
- HatzenbuehlerJPullingTJDiagnosis and management of osteomyelitisAm Fam Physician20118491027103322046943
- LindbloomBJJamesERMcGarveyWCOsteomyelitis of the foot and ankle: diagnosis, epidemiology, and treatmentFoot Ankle Clin201419356958825129362
- PanteliMPuttaswamaiahRLowenbergDWGiannoudisPVMalignant transformation in chronic osteomyelitis: recognition and principles of managementJ Am Acad Orthop Surg201422958659425157040
- SennevilleENguyenSCurrent pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawnExpert Opin Pharmacother201314672373423496344
- JacquelineCCaillonJImpact of bacterial biofilm on the treatment of prosthetic joint infectionsJ Antimicrob Chemother201469Suppl 1i37i4025135088
- ValourFBouazizAKarsentyJLyon BJI Study GroupDeterminants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort studyBMC Infect Dis201414144325128919
- FleiterNWalterGBösebeckHClinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitisBone Joint Res20143722322925005841
- RodvoldKAMcConeghyKWMethicillin-resistant Staphylococcus aureus therapy: past, present, and futureClin Infect Dis201458Suppl 1S20S2724343828
- RostasSEKubiakDWCalderwoodMSHigh-dose intravenous vancomycin therapy and the risk of nephrotoxicityClin Ther20143671098110124931573
- TanHLLinWTTangTTThe use of antimicrobial-impregnated PMMA to manage periprosthetic infections: controversial issues and the latest developmentsInt J Artif Organs2012351083283923138709
- BabuRJSathigariSKumarMTPanditJKFormulation of controlled release gellan gum macro beads of amoxicillinCurr Drug Deliv201071364319863487
- CaoZJiangDYanLWuJIn vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffoldJ Biomater Appl201630101566157726686585